↓ Skip to main content

Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification

Overview of attention for article published in Drugs, September 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
18 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Published in
Drugs, September 2023
DOI 10.1007/s40265-023-01938-w
Pubmed ID
Authors

Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 9 14%
Researcher 8 13%
Student > Ph. D. Student 6 9%
Professor 4 6%
Student > Doctoral Student 3 5%
Other 11 17%
Unknown 23 36%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 9 14%
Unspecified 8 13%
Neuroscience 8 13%
Medicine and Dentistry 5 8%
Biochemistry, Genetics and Molecular Biology 4 6%
Other 4 6%
Unknown 26 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2023.
All research outputs
#1,378,625
of 25,368,786 outputs
Outputs from Drugs
#120
of 3,464 outputs
Outputs of similar age
#23,211
of 351,170 outputs
Outputs of similar age from Drugs
#2
of 25 outputs
Altmetric has tracked 25,368,786 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,464 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,170 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.